Provided by Tiger Trade Technology Pte. Ltd.

Janux Therapeutics, Inc.

17.94
-1.3900-7.19%
Volume:348.93K
Turnover:6.45M
Market Cap:1.10B
PE:-10.92
High:19.33
Open:19.17
Low:17.94
Close:19.33
52wk High:35.34
52wk Low:12.12
Shares:61.14M
Float Shares:42.53M
Volume Ratio:0.41
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6429
EPS(LYR):-1.8336
ROE:-10.70%
ROA:-8.80%
PB:1.18
PE(LYR):-9.78

Loading ...

Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Jan 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2026

Major Issues Report

Form 8-K - Current report
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Oct 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2025

Major Issues Report

Form 8-K - Current report
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Major Issues Report

Form 8-K - Current report
May 09, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities